Literature DB >> 1252171

Editorial: Dangers of steroid treatment in toxoplasmosis. Periocular injections and systemic therapy.

G R O'Connor, J K Frenkel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 1252171     DOI： 10.1001/archopht.1976.03910030093001

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


× No keyword cloud information.
  9 in total

Review 1.  Corticosteroids as adjuvant therapy for ocular toxoplasmosis.

Authors:  Smitha Jasper; Satyanarayana S Vedula; Sheeja S John; Saban Horo; Yasir J Sepah; Quan Dong Nguyen
Journal:  Cochrane Database Syst Rev       Date:  2017-01-26

Review 2.  Uveitis. A review.

Authors:  C Y Lowder; D H Char
Journal:  West J Med       Date:  1984-03

Review 3.  Ocular toxoplasmosis in the immunocompromised host.

Authors:  G N Holland
Journal:  Int Ophthalmol       Date:  1989-12       Impact factor: 2.031

4.  Protective role of nitric oxide in ocular toxoplasmosis.

Authors:  S Hayashi; C C Chan; R T Gazzinelli; N T Pham; M K Cheung; F G Roberge
Journal:  Br J Ophthalmol       Date:  1996-07       Impact factor: 4.638

Review 5.  Corticosteroids as adjuvant therapy for ocular toxoplasmosis.

Authors:  Smitha Jasper; Satyanarayana S Vedula; Sheeja S John; Saban Horo; Yasir J Sepah; Quan Dong Nguyen
Journal:  Cochrane Database Syst Rev       Date:  2013-04-30

6.  Fulminant toxoplasmic retinochoroiditis following intravitreal triamcinolone administration.

Authors:  Ryan Rush; Saumil Sheth
Journal:  Indian J Ophthalmol       Date:  2012 Mar-Apr       Impact factor: 1.848

7.  Intravitreal Clindamycin as First-Line Therapy for Toxoplasmic Retinochoroiditis: A Case Series.

Authors:  Lalit Verma; Mithun Thulasidas; Avnindra Gupta
Journal:  Clin Ophthalmol       Date:  2020-12-07

8.  Intravitreal clindamycin in the treatment of unresponsive zone one toxoplasmic chorioretinitis: a case report.

Authors:  Seyedeh Maryam Hosseini; Mojtaba Abrishami; Mehran Mehdi Zadeh
Journal:  Iran Red Crescent Med J       Date:  2014-11-17       Impact factor: 0.611

9.  Toxoplasma retinitis following intravitreal injection of triamcinolone acetonide: A case report and review of literature.

Authors:  Arshee Ahmed; Sridharan Sudharshan; Sriram Gopal; Parthopratim Dutta Majumder; Jyotirmay Biswas
Journal:  Indian J Ophthalmol       Date:  2018-08       Impact factor: 1.848
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.